<h1>Datar Cancer Genetics appoints expert with 400+ publications as Strategic Advisor to boost early cancer detection and treatment.</h1> Datar Cancer Genetics (DCG), a leader in non-invasive cancer diagnostics, has appointed a renowned expert as their Strategic Advisor to enhance early cancer detection and precision treatment. The expert, with over 400 publications on cancer biomarkers and liquid biopsy, will collaborate with DCG to innovate cancer diagnostic tests. This partnership aims to strengthen DCG's leadership in molecular tumor profiling and liquid biopsies, focusing on circulating tumor cells. DCG operates globally, providing advanced cancer detection and treatment solutions, with research centers accredited in the UK and India, serving patients in multiple regions including the US and EU.